COMPOUNDED TIRZEPATIDE
US$ 28.86
glp-1 drugs and breast cancer Receptor Agonists in Cancer: A New Frontier in Obesity Prognosis Management Could GLP-1 drugs help breast
Description
A thorough medical evaluation is needed to determine if this treatment is a safe and effective choice for you
BMC Musculoskelet
Pang, B., et al
Because they're classed as food supplements, they don't go through the same safety checks as prescription medications
Secondary outcomes Secondary outcomes included cardiovascular mortality, all-cause mortality, non-fatal myocardial infarction (MI) and stroke, as well as hospitalisation for heart failure
